Invention Grant
- Patent Title: Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
-
Application No.: US15804445Application Date: 2017-11-06
-
Publication No.: US10465192B2Publication Date: 2019-11-05
- Inventor: Joseph Collard , Olga Khorkova Sherman , Carlos Coito
- Applicant: CuRNA, Inc.
- Applicant Address: US FL Miami
- Assignee: CuRNA, Inc.
- Current Assignee: CuRNA, Inc.
- Current Assignee Address: US FL Miami
- Agency: CuRNA, Inc.
- Agent Monte R. Browder
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C12N5/00
Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Delta-like 1 homolog (DLK1), in particular, by targeting natural antisense polynucleotides of Delta-like 1 homolog (DLK1). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of DLK1.
Public/Granted literature
Information query
IPC分类:
